Roch P, Aubert B
PRP-HOM/SER/UEM, Institut de Radioprotection et de Sureté Nucléaire, BP 17, 92262 Fontenay-aux-Roses, France.
Radiat Prot Dosimetry. 2013 Apr;154(1):52-75. doi: 10.1093/rpd/ncs152. Epub 2012 Sep 6.
After 5 y of collecting data on diagnostic reference levels (DRLs), the Nuclear Safety and Radiation Protection French Institute (IRSN) presents the analyses of this data. The analyses of the collected data for radiology, computed tomography (CT) and nuclear medicine allow IRSN to estimate the level of regulatory application by health professionals and the representativeness of current DRL in terms of relevant examinations, dosimetric quantities, numerical values and patient morphologies. Since 2004, the involvement of professionals has highly increased, especially in nuclear medicine, followed by CT and then by radiology. Analyses show some discordance between regulatory examinations and clinical practice. Some of the dosimetric quantities used for the DRL setting are insufficient or not relevant enough, and some numerical values should also be reviewed. On the basis of these findings, IRSN formulates recommendations to update regulatory DRL with current and relevant examination lists, dosimetric quantities and numerical values.
在收集诊断参考水平(DRLs)数据5年后,法国核安全与辐射防护研究所(IRSN)公布了对这些数据的分析结果。对放射学、计算机断层扫描(CT)和核医学收集数据的分析,使IRSN能够评估卫生专业人员的监管应用水平,以及当前DRL在相关检查、剂量学量、数值和患者形态方面的代表性。自2004年以来,专业人员的参与度大幅提高,尤其是在核医学领域,其次是CT,然后是放射学。分析表明,监管检查与临床实践之间存在一些不一致。一些用于设定DRL的剂量学量不够充分或相关性不足,一些数值也应重新审视。基于这些发现,IRSN制定了相关建议,以根据当前和相关的检查清单、剂量学量和数值来更新监管DRL。